United Kingdom
  • Booth: 831

Creating a new standard in genomic medicine


Congenica is the provider of the diagnostic decision support platform, Sapientia, and associated clinical services, which enable clinicians to interrogate the human genome to identify disease-causing variants. Sapientia is intuitive to use, supporting the routine diagnostic workflow whilst enabling clinicians to progress through cases more quickly, optimizing throughput of patients and diagnoses. Headquartered in Cambridge, UK, and with a footprint in the US and China, Congenica is borne out of pioneering research from the Wellcome Trust Sanger Institute and the NHS. Their product, Sapientia™ has been comprehensively evaluated in the UK 100,000 Genomes Project and is the chosen partner for use by the NHS in the national genomic medicine programme in the UK.